Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Orrell

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
The Cochrane Database of Systematic Reviews|October 21, 2004
Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron diseaseR W Orrell, J M Lane, M A Ross
Paraplegia|July 1, 1991
Myotonic dystrophy and traumatic quadriplegia: case reportR W Orrell, A M Tromans, A A Burt
Journal of Neurochemistry|June 15, 2005
ALS-IgG-induced selective motor neurone apoptosis in rat mixed primary spinal cord culturesM Demestre, A Pullen, R W Orrell, et al.
The Cochrane Database of Systematic Reviews|January 27, 2007
Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron diseaseR W Orrell, R J M Lane, M Ross
BMJ (Clinical Research Ed.)|July 16, 1994
Recent developments in the drug treatment of motor neurone diseaseR W Orrell, R J Lane, R J Guiloff
The Cochrane Database of Systematic Reviews|January 28, 2005
Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron diseaseR W Orrell, R J M Lane, M Ross
Journal of the Neurological Sciences|February 10, 1998
Familial ALS is associated with mutations in all exons of SOD1: a novel mutation in exon 3 (Gly72Ser)R W Orrell, S L Marklund, J S deBelleroche
Lancet (London, England)|February 11, 1995
Parental influence on inheritance of familial amyotrophic lateral sclerosisR W Orrell, A W King, J S deBelleroche
Lancet (London, England)|March 30, 1991
Nose-blowing and CSF rhinorrhoeaR W Orrell, J A Guthrie, J T Lamb
Neuropathology and Applied Neurobiology|April 8, 2006
Serine proteases purified from sera of patients with amyotrophic lateral sclerosis (ALS) induce contrasting cytopathology in murine motoneurones to IgGM Demestre, R S Howard, R W Orrell, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
The Cochrane Database of Systematic Reviews|October 21, 2004
Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron diseaseR W Orrell, J M Lane, M A Ross
Paraplegia|July 1, 1991
Myotonic dystrophy and traumatic quadriplegia: case reportR W Orrell, A M Tromans, A A Burt
Journal of Neurochemistry|June 15, 2005
ALS-IgG-induced selective motor neurone apoptosis in rat mixed primary spinal cord culturesM Demestre, A Pullen, R W Orrell, et al.
The Cochrane Database of Systematic Reviews|January 27, 2007
Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron diseaseR W Orrell, R J M Lane, M Ross
BMJ (Clinical Research Ed.)|July 16, 1994
Recent developments in the drug treatment of motor neurone diseaseR W Orrell, R J Lane, R J Guiloff
The Cochrane Database of Systematic Reviews|January 28, 2005
Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron diseaseR W Orrell, R J M Lane, M Ross
Journal of the Neurological Sciences|February 10, 1998
Familial ALS is associated with mutations in all exons of SOD1: a novel mutation in exon 3 (Gly72Ser)R W Orrell, S L Marklund, J S deBelleroche
Lancet (London, England)|February 11, 1995
Parental influence on inheritance of familial amyotrophic lateral sclerosisR W Orrell, A W King, J S deBelleroche
Lancet (London, England)|March 30, 1991
Nose-blowing and CSF rhinorrhoeaR W Orrell, J A Guthrie, J T Lamb
Neuropathology and Applied Neurobiology|April 8, 2006
Serine proteases purified from sera of patients with amyotrophic lateral sclerosis (ALS) induce contrasting cytopathology in murine motoneurones to IgGM Demestre, R S Howard, R W Orrell, et al.
Pageof 6